The Food and Drug Administration in recent months has approved a small number of drugs quite quickly under a new expedited ...
Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of phase one clinical trials and applications to the FDA at the end of the ...
Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the first Trump Administration, though the portions of the order relating to the ...
Evansville, Ind. — Lavender Timmons popped the trunk of her weather-beaten 2007 Ford Focus parked near the city’s homeless shelter. Regulars gathered around, including one drug user who in the past ...